Literature DB >> 8096040

Indeterminate hepatitis C.

X M Li, K R Reddy, L J Jeffers, T Parker, M de Medina, E R Schiff.   

Abstract

Mesh：

Substances：

Year:  1993        PMID： 8096040     DOI： 10.1016/0140-6736(93)90616-o

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Clinical guidelines on the management of hepatitis C.

Authors:  J C Booth; J O'Grady; J Neuberger
Journal:  Gut       Date:  2001-07       Impact factor: 23.059

2.  Analysis of sera indeterminate by Ortho-HCV RIBA-2 by using three confirmatory assays for anti-hepatitis C virus antibody.

Authors:  E Dussaix; N Charnaux; P Laurent-Puig; S Chopineau; Y Laurian; C Buffet
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

3.  Infection with hepatitis C virus. New generation of assays should improve screening.

Authors:  N Hallam; J Kurtz; A Dike; D Parker
Journal:  BMJ       Date:  1994-03-26

4.  Significance of indeterminate third-generation hepatitis C virus recombinant immunoblot assay.

Authors:  J M Pawlotsky; A Bastie; C Pellet; J Remire; F Darthuy; L Wolfe; C Sayada; J Duval; D Dhumeaux
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

5.  Significance of highly positive c22-3 "indeterminate" second-generation hepatitis C virus (HCV) recombinant immunoblot assay (RIBA) and resolution by third-generation HCV RIBA.

Authors:  J M Pawlotsky; A Fleury; V Choukroun; L Deforges; F Roudot-Thoraval; P Aumont; J Duval; D Dhumeaux
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.